News-Medical.Net on MSN18h
Mouse and organoid models reveal FGFR2's role in pancreatic cancer aggression and interception
Pancreatic cancer is projected to become the second-deadliest cancer by 2030. By the time it's diagnosed, it's often ...
News Medical on MSN6h
Study sheds light on how major cancer gene influences the success of PARP inhibitors
A study led by scientists at NYU Langone Health sheds light on how the major cancer gene BRCA2 determines which cancer cells can be killed by a class of precision cancer drugs called PARP inhibitors.
360Dx12h
Purdue Spinout Amplified Sciences Aims for Improved Early Cancer Detection
NEW YORK – With the launch of its first product, a rule-out test for pancreatic cysts that can help risk-stratify patients who may have pancreatic cancer, Purdue University spinout Amplified Sciences ...
Apollomics Reports Full Year 2024 Financial Results and Highlights Clinical Updates and Business Progress
Strategic collaboration with LaunXP for the development of vebreltinib in combination with an EGFR inhibitor (“EGFRi”) to bring in $10 million ...
PanCan Purple Stride: Local action. Nationwide impact.
On Saturday, April 26, 2025, take steps with survivors, families, caregivers, friends, physicians and researchers at our ...